Applied BioSciences Announces Partnership with Boxing Heavyweight Champion Shannon Briggs

Through this new partnership, Briggs and the company will work together to formulate a line of athlete-focused, CBD-based health and wellness supplements.

March 20, 2019

LOS ANGELES, March 20, 2019 (GLOBE NEWSWIRE) -- PRESS RELEASE -- Applied Biosciences Corp., a diversified cannabinoid therapeutics company focused on the medical, bioceutical, testing and pet health industries, has announced that it has signed a partnership agreement with Shannon “the Cannon” Briggs, the former heavyweight boxing champion and world record-holder for the most first-round knockouts.

Through this new partnership, Briggs and the company will work together to formulate a line of athlete-focused, cannabidiol (CBD)-based health and wellness supplements to enhance training and recovery under the “Champ Organics” brand.

Additionally, Briggs and the company will collaborate on an awareness campaign to help educate athletes around the world about the potential benefits of using CBD for pain management, relaxation, decreasing anxiety and improving sleep quality. Briggs hopes to educate the public on the potential benefits of using CBD to help decrease dependence on opioids.

“I have partnered with Applied BioSciences to develop and market Champ Organics because their products are made with the highest quality ingredients and all-natural CBD. I am a firm believer in the benefits that CBD delivers for joint pain and headaches. Since I have incorporated CBD to my daily supplements, I have been surprised by the positive impact it has had on my overall quality of life," commented Briggs.

“Every day, roughly 130 Americans die from opioid overdoses,” noted Briggs. “Meanwhile, a recent study in the Journal of the American Medical Association showed that in states where people could legally use cannabis, the number of filled opioid prescriptions dropped significantly, and there were lower rates of opioid overdose and death.”

“The all-natural formulations of Applied Biosciences’ Remedi CBD products attracted Briggs to our company,” commented Chris Bridges, president and director of Applied Biosciences. “Our company’s aligned mission to end the country’s opioid epidemic was what made him choose Applied in the end. This partnership will allow us to expand into a new vertical and additional distribution channels globally."